Hypertension, Vol 12, 1-10, Copyright © 1988 by American Heart Association
S Bansal
Sexual dysfunction is common in hypertensive men and often is first
reported by patients while receiving hypotensive therapy, leading to a
widespread belief by patients and physicians that the sexual dysfunction is
caused by a specific antihypertensive medication. However, it is unclear
from the literature whether this problem is related to hypertension or to
its therapy. Further, whether the erectile failures reported during therapy
are a result of 1) reduced penile blood flow secondary to reduction of
blood pressure after antihypertensive treatment or to obstructive vascular
disease (or both) or 2) specific drug effects has not been well studied.
Because of these unresolved issues, this common problem is not well managed
and contributes to noncompliance with therapy by hypertensive male
patients, which impedes the attainment of satisfactory blood pressure
control. The present article reviews the literature related to hypertension
and sexual function in men and outlines a management strategy for
clinicians that attempts to document normalcy of sexual function before
initiating treatment in newly diagnosed hypertensive patients. Further, it
does not ascribe causality to specific antihypertensive agents for the
sexual dysfunction reported by treated hypertensive patients but attempts
instead to delineate the pathogenesis of the dysfunction. Once the
pathogenesis is established, treatment plans can be implemented to restore
normotension and maintain adequate sexual function among treated
hypertensive men. The article also discusses how applied research in this
area may be performed.
ARTICLES
Sexual dysfunction in hypertensive men. A critical review of the literature
VA Medical Center, Providence, RI.
This article has been cited by other articles:
![]() |
S. Gur, P. J. Kadowitz, S. Thammasitboon, J. A. Lasky, and W. J. G. Hellstrom Characterization of Erectile Function in Monocrotaline-Treated Pulmonary Hypertensive Rats J Androl, September 1, 2009; 30(5): 495 - 504. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. Papatsoris and P. G. Korantzopoulos Hypertension, Antihypertensive Therapy, and Erectile Dysfunction Angiology, January 1, 2006; 57(1): 47 - 52. [Abstract] [PDF] |
||||
![]() |
S. M Setter, J. L Iltz, J. E Fincham, R K. Campbell, and D. E Baker Phosphodiesterase 5 Inhibitors for Erectile Dysfunction Ann. Pharmacother., July 1, 2005; 39(7): 1286 - 1295. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. T. Russell, B. K. Khandheria, and A. Nehra Erectile Dysfunction and Cardiovascular Disease Mayo Clin. Proc., June 1, 2004; 79(6): 782 - 794. [Abstract] [PDF] |
||||
![]() |
W. Alexander Erectile dysfunction The British Journal of Diabetes & Vascular Disease, July 1, 2002; 2(4): 244 - 246. [PDF] |
||||
![]() |
R. H. Grimm Jr, G. A. Grandits, R. J. Prineas, R. H. McDonald, C. E. Lewis, J. M. Flack, C. Yunis, K. Svendsen, P. R. Liebson, P. J. Elmer, et al. Long-term Effects on Sexual Function of Five Antihypertensive Drugs and Nutritional Hygienic Treatment in Hypertensive Men and Women: Treatment of Mild Hypertension Study (TOMHS) Hypertension, January 1, 1997; 29(1): 8 - 14. [Abstract] [Full Text] |
||||
![]() |
L. M. Prisant, A. A. Carr, P. B. Bottini, D. S. Solursh, and L. P. Solursh Sexual Dysfunction With Antihypertensive Drugs Arch Intern Med, April 11, 1994; 154(7): 730 - 736. [Abstract] [PDF] |
||||
![]() |
S. Wassertheil-Smoller, M. D. Blaufox, A. Oberman, B. R. Davis, C. Swencionis, M. O. Knerr, C. M. Hawkins, and H. G. Langford Effect of Antihypertensives on Sexual Function and Quality of Life: The TAIM Study Ann Intern Med, April 15, 1991; 114(8): 613 - 620. [Abstract] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1988 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |